A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
We will conduct a trial to determine whether paclitaxel/cisplatin (TP) as an adjuvant chemotherapy after radical surgery improve disease-free survival (DFS) and overall survival (OS), as well as the quality of life (QoL) among early-stage (FIGO stage IB-IIA) cervical cancer patients with risk factors.
Epistemonikos ID: 4d4753c648bcefea119517ab2c2cbd419e6114eb
First added on: May 11, 2024